Introduction {#Sec1}
============

The mechanism of liver regeneration is still not fully understood. Although vigorous liver regeneration after living-donor liver transplantation (LDLT) has been reported by us and others \[[@CR1]--[@CR3]\], it has been assessed by imaging studies such as computed axial tomography (CAT) scan, not hepatocyte cell division. In the present study, we took the opportunity to use liver biopsy specimens to verify liver regeneration in partial liver recipients during various periods after LDLT.

In addition, during liver regeneration it has been reported that extrahepatic cells, especially bone marrow (BM)-derived cells, are mobilized and involved \[[@CR4]--[@CR6]\]. However, details regarding how extrahepatic cells are involved and how much they contribute to normal liver regeneration have not been fully elucidated \[[@CR7]--[@CR10]\]. Therefore, we investigated liver biopsy specimens from female-donor male-recipient grafts, in which only XX cells should be present in the graft liver. We used fluorescent in situ hybridization (FISH) to detect Y chromosomes in the liver to identify extrahepatic cells in the liver upon liver regeneration.

Materials and Methods {#Sec2}
=====================

Patients {#Sec3}
--------

Of 61 patients who underwent LDLT between August 1997 and October 2006 at Nagasaki University Hospital, 56 Japanese patients with survival times of more than 3 months were included for volumetric analysis. For adult recipients, right lobe grafts were transplanted in 40 recipients, while left-side grafts (8 extended left lobe graft, 1 left lobe graft) were performed in 9 recipients. Seven pediatric cases with left lateral lobe graft also underwent volumetric study. Adult patients were defined as those over 16 years old. When liver function test was deranged, total 93 liver biopsies were carried out, consisting of 83 in adult cases and 10 in pediatric cases, and were prepared for proliferative cell nuclear antigen (PCNA) staining. Within these, a total of 24 liver biopsies were performed in 15 recipients on indication from a pool of 19 male recipients (XY) who were transplanted with female livers (XX).

Methods of LDLT {#Sec4}
---------------

All partial liver grafts were preserved in University of Wisconsin solution and implanted using a piggyback technique. In general, graft selection was based on the results of volumetric studies using CAT scans to obtain ratios of graft volume to standard liver volume of more than 35% in the recipients.

A dual or triple immunosuppressive regimen was used, which included tacrolimus or cyclosporine A, steroid, and mycophenolate mofetil. Patients with compromised renal function were given induction therapy with interleukin-2 antibodies. Biopsy-proven rejections were treated if clinical and laboratory signs mandated steroid bolus treatment. Steroid-resistant rejections were treated with OKT3.

Investigation for Liver Regeneration {#Sec5}
------------------------------------

Incremental growth of the liver in volume was measured by serial CAT scans using Flexi Trace software (Tree Star, Inc., U.S.A.) at 0, 1--2 weeks, and 3 months after LDLT \[[@CR1]\]. In liver biopsy specimens, expression of PCNA (DACO, Carpinteria, CA) was analyzed for intrahepatic proliferation \[[@CR11]\].

Four-micrometer liver sections were deparaffinized in xylene and hydrated in graded ethanol. After deparaffinization, rehydration, and heating in 95°C buffer, sections were incubated with each antibody and subsequently with Histofine Simple Stain MAX-PO (MULTI) (Nichirei, Japan). Incubation was performed overnight at 4°C and followed by a wash in three changes of phosphate buffered saline (PBS) for 5 min. For all stainings, the reaction product was developed with the use of 3-diaminobenzidine tetrahydrochloride and H~2~O~2~. The sections were counterstained with Meyer hematoxylin--eosin.

For hepatocyte staining, the goat anti-human hepatocyte-specific antigen Ab (R&D system, Minneapolis, MN), and 2nd Ab biotinylated rabbit anti-goat Ig (DAKO, Carpinteria, CA) were used. For the staining of CK7 (bile duct marker), CD68 (macrophage marker) and CD34 (hematopoietic cells) were used, respectively, according to the manufacturer's protocol.

Fluorescent In Situ Hybridization (FISH) {#Sec6}
----------------------------------------

FISH was performed in our reference laboratory (SRL, Nagasaki, Japan). Sections from paraffin-embedded biopsied liver tissues were placed on silane-coated glass slides. The slides were deparaffinized immediately in two rinses of 1,000 g/l xylene for 10 min each. Each slide was rehydrated in an ethanol series for 5 min. The slides were then treated with 0.2 mol/l HCl for 20 min, followed by 2 × SSC (0.3 mol/l sodium chloride and 0.03 mol/l sodium citrate) for 20 min at 80°C, treated with 0.05 mg/ml proteinase K in TEN \[0.05 mol/l Tris--HCl, pH 7.8, 0.01 mol/l ethylenediamine tetraacetic acid (EDTA), and 0.01 mol/l sodium chloride\] for 10 min at 37°C, and placed in 40 g/l formaldehyde in PBS for 10 min. Both FISH probes and target DNA were denatured simultaneously for 10 min at 90°C, and the slides were incubated overnight at 42°C, placed in 2 × SSC for 10 min at 42°C, washed twice in 2 × SSC/500 g/l formaldehyde formamide for 5 min each at 42°C, washed 2 × SSC for 5 min at 42°C, and counterstained in 2 × SSC/0.03 μg/ml 4',6-diamidino-2-phenylindole (DAPI).

Statistical Analysis {#Sec7}
--------------------

For the data, Mann--Whitney *U* test was used. Differences were considered statistically significant for *P*-value less than 0.05.

Results {#Sec8}
=======

Liver Volume {#Sec9}
------------

Graft volume per standard liver volume at 0, 1, 3, and 6 months after adult-to-adult LDLT was 53.2%, 95.9%, 98.5%, and 101.2% in right lobe grafts and 41.1%, 81.9%, 92.7%, and 102.4% in left-sided grafts, respectively (Fig. [1](#Fig1){ref-type="fig"}). Since volume changes in pediatric LDLT were not evident, they are not included in the figure.Fig. 1Liver regeneration of right lobe or left lobe graft liver after adult-to-adult LDLT using volumetric analysis using CAT scan. *LDLT* living-donor liver transplantation, *CAT* computed axial tomography

DNA Synthesis in the Liver {#Sec10}
--------------------------

PCNA labeling index was vigorous in adult-to-adult LDLT in the early period after LDLT, while it was not evident in pediatric LDLT (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2PCNA labeling index after LDLT using immunohistochemical staining. *PCNA* proliferating cell nuclear antigen, *LDLT* living-donor liver transplantation

FISH and Immunohistochemical Staining for Y-Positive Cells {#Sec11}
----------------------------------------------------------

Y chromosome was not evident in hepatocytes of female-donor male-recipient grafts after normal liver regeneration in adult-to-adult LDLT recipients (Fig. [3](#Fig3){ref-type="fig"}, case 1). As seen in this case, when graft livers did not receive any damage and underwent normal liver regeneration, existence of Y-chromosome-positive cells was limited with FISH examination. However, in the case of failing graft, such as in cases 11--13, many Y-chromosome-positive cells were observed in zone 1 of the graft liver (Fig. [3](#Fig3){ref-type="fig"}, case 11).Fig. 3FISH for Y chromosome in liver biopsy specimens. Case 1 showed normal liver regeneration after LDLT. **a** At the time of LDLT, few Y-chromosome-positive cells were seen. **b** With time, although GV/SLV increased, a few Y-chromosome-positive cells were seen only in the sinusoid. **c** Case 11 had severe acute rejection at 1 week after LDLT. **d** In the biopsy specimen, massive accumulation of Y-chromosome-positive cells was seen, mimicking hepatic structure. *FISH* fluorescent in situ hybridization, *GV/SLV* graft volume versus standard liver volume ratio

For these cases, immunohistochemical staining was performed in the area with Y chromosomes. CD34(−), CK9(−), hepatocyte Ag(−), and CD68(+/−) were observed using immunohistochemical staining (Fig. [4](#Fig4){ref-type="fig"}, case 11). In the case of chronic liver damage (Fig. [5](#Fig5){ref-type="fig"}, case 15) after LDLT due to biliary complication, a few Y-positive cells were also detected with nonspecific staining for CD34, CK9, hepatocyte Ag, and CD68. Results of immunohistochemical staining are summarized in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}.Fig. 4Immunohistochemical stainings in case 11. Characterization of Y-chromosome-positive cells was attempted in corresponding area. **a** FISH showing Y-chromosome-positive cells (white square), **b** hepatocyte antigen was not positive in the black square, **c** CK7 (cytokeratin 7, bile duct) was not positive in the black square, **d** hematoxylin and eosin staining, **e** CD68 (macrophage) was partially positive in the black square, **f** CD34 (hematopoietic cell) was not positive in the black squareFig. 5Immunohistochemical stainings in case 15, secondary biliary cirrhosis after LDLT. **a** FISH showing Y-chromosome-positive cells (white square), **b** Azan staining was positive, showing the presence of liver fibrosis, **c** CK7 (cytokeratin 7, bile duct) was not positive in the black square, **d** CD68 (macrophage) was partially positive in the black square, **e** CD34 (hematopoietic cell) was not positive in the black square. *LDLT* living-donor liver transplantationTable 1Demographics of male recipients with female donorsCase no.AgeGenderEtiologyDonorBlood type matchGraph typeBiopsy period after LDLTCommentsOutcome116MFHFMotherIdenticalL3d, 4YNoneSurvived25MBAMotherIdenticalLL2M, 8YCholestasisSurvived356MLC-B/HCCSisterIdenticalR1.5M, 1.8Y, 2Y mild ACRNoneSurvived420MFHFAuntIdenticalR1M, 5M, 2YCholestasisSurvived558MLC-CSisterIdenticalR2MHepatitisSurvived656MLC-B/HCCDaughterIdenticalR8MVanishing BDSurvived756MLC-B/HCCDaughterIdenticalR9M (Re-LDLT)Poor qualitySurvived856MLC-B/HCCWifeIdenticalR6MMild ACRSurvived958MLC-C/HCCDaughterIncompatibleR3WHepatitisSurvived1062MLC-CSisterCompatibleL1.5MModerate ACRSurvived1141MPBCWifeIdenticalR1W, 1M (autopsy)Severe ACRDied (2M)1250MLC-BWifeIdenticalR10d (graft failure)MalcirculationDied (1M)1357MLC-C/HCCWifeIdenticalR10d, 2M (graft failure)Moderate ACRDied (2M)1447MLC-AlSisterIdenticalR3.8Y (liver cirrhosis)Poor qualityDied (3.8Y)1551MLC-CSisterIdenticalR2.5Y (chronic liver failure)Biliary cirrhosisDied (2.5Y)*FHF* fulminant hepatic failure, *BA* biliary atrasia, *ACR* acute cellular rejection, *LC-B* liver cirrhosis due to hepatitis B, *LC-C* liver cirrhosis due to hepatitis C, *LC-Al* liver cirrhosis due to alcohol hepatitis, *HCC* hepatocellular carcinoma, *PBC* primary biliary cirrhosis, *d* days, *M* months, *Y* years, *LDLT* living-donor liver transplantationTable 2Summary of resultsNormal regenerationAcute graft failureChronic graft failureY chromosome−+++Hepatocyte antigen−−−CK7 (bile duct)−−−CD68 (macrophage)−Partial +−CD34 (hematopoietic)−++

Discussion {#Sec12}
==========

In this report, we showed liver regenerative response after partial LT using not only volumetric CAT scan study but also PCNA labeling of biopsy specimens. Previously, we reported vigorous liver regenerative response after partial liver regeneration and investigated liver regenerative growth factors after liver regeneration \[[@CR11]\]. Herein, we showed a clear difference in proliferation of graft liver according to recipient body size and blood flow due to the difference in responses when transplanted in adults and children with different standard liver volumes. We did not carry out statistical analysis on PCNA index since it exhibited wide deviation. Liver regeneration remains an unsolved phenomenon, but our results show that it could be related to factors in recipients, as we reported previously \[[@CR1]\]. Since protocol biopsy tends to be avoided because of risk of hemorrhage etc., further investigation is needed to assess cell proliferation noninvasively aside from CAT scan. Also since liver biopsy was not done on protocol, rejection or inflammation could have affected the data of PCNA staining. Although it would be interesting to investigate the difference in liver regeneration between patients after liver resection and those after partial liver transplantation, biopsy specimen from patients after liver resection cannot be obtained because of risk of complications. Therefore this also remains for further investigation. Our liver specimens from liver transplant recipients were obtained because of on-demand liver biopsy.

In addition, for combinations of female donor (XX) and male recipient (XY), the Y chromosome was investigated in the biopsy specimen of the female liver (XX) in order to investigate the contribution of extrahepatic cells to liver regeneration. Previously, in an in vivo experiment conducted in 2000, it was reported that hepatocytes could be derived from BM cells \[[@CR12]\]. Subsequently, in 2001, Baccarani et al. \[[@CR13]\] reported that, in human recipients, replacement of a female liver venous endothelium with male BM showed the possibility of involvement of BM cells in liver rearrangement. Fujii et al. \[[@CR4]\] reported that BM cells participated in liver regeneration after hepatectomy, whereas the majority of cells were committed to sinusoidal endothelial cells. Very recently, Conzelmann et al. \[[@CR5]\], using their reduced-size LT model, reported that recipient-derived progenitor cells were present and might contribute to liver regeneration in mice. However, in 2005 Di Campli et al. \[[@CR7]\] reported no evidence of hematopoietic stem cell mobilization in patients who underwent hepatectomy or in patients with acute liver failure. Similarly, in 2006, Moritoki et al. \[[@CR8]\], using green fluorescent protein transgenic mice, demonstrated that BM cell transfer seemed not to contribute to the differentiation of cholangiocytes in a chronic cholestasis model. In 2007, Tomiyama \[[@CR6]\] reported the limited contribution of cells originating from intact extrahepatic tissue in hepatocyte regeneration in transplanted rat livers. Thus, it is still unknown whether extrahepatic cells such as BM cells could contribute to liver regeneration or liver repair, especially in humans.

In our study, we did not find many Y-chromosome-positive cells after liver transplantation with normal liver regeneration. If extrahepatic cells had been involved and integrated into normal liver regeneration, they should have stayed and been found in the liver biopsied a long time after LDLT. This is indirect evidence that would seem to rule out extrahepatic cell contribution to normal liver regeneration in humans, in contrast to previous reports \[[@CR12], [@CR13]\]. On the other hand, when failing livers were biopsied, many Y-chromosome-positive cells were present. Although we could not clearly show the origin of those Y-positive cells, circulating macrophages were candidate sources because some cells were positive for CD68, which we used to identify macrophages. However, CD34, used for hematopoietic cells, was negative, which indicated that those Y-positive cells did not have hematopoietic origins. In addition, there may be significant sampling variability in liver biopsy specimens from a single liver biopsy, which may not necessarily be representative of the entire liver. In liver chronically damaged by biliary complication, Y-chromosome-positive cells were not as numerous as seen in the case of acute graft failure. In addition, despite the information about expression of progenitor cell markers such as c-kit and Thy-1, we did not investigate this in this study; this awaits further investigation. With regard to CD68(+) Y chromosome(+) cells, we presume that they are regular macrophages from recipient side to dispose of damaged cells in failing liver, not special multipotent stem cells expressing CD68.

In conclusion, in adult-to-adult LDLT, vigorous liver regeneration occurs in graft livers. Involvement of extrahepatic cells in normal adult-to-adult liver regeneration seems limited.
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